Effect of 5-hydroxytryptamine-2 and α-adrenergic receptor antagonists on the 5-hydroxytryptamine-induced decrease in rabbit masseter muscle blood flow

Archives of Oral Biology

Volumn 44, Issue 8, 1999, Pages 651-656

  Kurita, Hiroshi ^a,b   Ernberg, Malin ^a   Tominaga, Kazuhiro ^a,c   Alstergren, Per ^a   Kopp, Sigvard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

Laser Doppler flowmetry; Microcirculation; Norepinephrine; Serotonin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; PHENTOLAMINE; RITANSERIN; SEROTONIN; SEROTONIN 2 ANTAGONIST; SEROTONIN ANTAGONIST;

ANIMAL; ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; DRUG EFFECT; LASER DOPPLER FLOWMETRY; MALE; MASSETER MUSCLE; MICROCIRCULATION; MUSCLE BLOOD FLOW; NONHUMAN; RABBIT; SEROTONINERGIC SYSTEM; TIME; VASCULARIZATION;

EID: 0345552040     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9969(99)00058-8     Document Type: Article

References (15)

1. 2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology. 35:1996;99-110.
2. Alsip N.L., Harris P.D. Receptor mediation of microvascular responses to serotonin in striated muscle. Am. J. Physiol. 261:1991;H1525-H1533.
3. Björnberg J., Grände P-O., Maspers M., Mellander S. Site of autoregulatory reactions in the vascular bed of cat skeletal muscles as determined with a new technique for segmental vascular resistance recordings. Acta Physiol. Scand. 133:1988;199-210.
4. Burnstock G. Mechanisms of interaction of peptide and nonpeptide vascular neurotransmitter systems. J. Cardiovasc. Pharmacol. 10:(Suppl. 12):1987;S74-S81.
5. Ernberg M., Hedenberg-Magnusson B., Alstergren P., Kopp S. Effect of local glucocorticoid injection on masseter muscle level of serotonin in patients with chronic myalgia. Acta Odontol. Scand. 56:1998;129-134.
6. 2-adrenoceptors. Am. J. Physiol. 255:(1 Pt 2):1988;H121-H130.
7. Frishman W.H., Huberfeld S., Okin S., Wang Y.H., Kumar A., Shareef B. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular tissue. J. Clin. Pharmacol. 35:1995;541-572.
8. 2 receptor antagonist. Adv. Exp. Med. Biol. 317:1992;759-764.
9. Hassall C.J.S., Burnstock G. Neuropeptide Y-like immunoreactivity in cultured intrinsic neurones of the heart. Neurosci. Lett. 52:1984;111-115.
10. Hassall C.J.S., Burnstock G. Intrinsic neurones and associated cells of the guinea-pig heart in culture. Brain Res. 364:1986;102-113.
11. Hedenberg-Magnusson B., Ernberg M., Kopp S. Symptoms and signs of temporomandibular disorders in patients with fibromyalgia and local myalgia of the temporomandibular system. A comparative study. Acta Odontol. Scand. 55:1997;344-349.
12. Kurita, H., Ernberg, M., Tominaga, K., Alstergren, P., Kopp, S., 1999. Effect of 5-hydroxytryptamine infusion on microcirculation in the rabbit masseter muscle measured by laser-Doppler flowmetry. Archives of Oral Biology (in press).
13. Mellander S., Björnberg J., Maspers M., Myrhage R. Method for continuous recording of hydrostatic exchange vessel pressure in cat skeletal muscle. Acta Physiol. Scand. 129:1987;325-335.
14. Van Nueten J.M., Janssens W.J., Vanhoutte P.M. Serotonin and vascular reactivity. Pharmacol. Res. Commun. 17:1985;585-608.
15. Wilmoth F.R., Harris P.D., Miller F.N. Differential serotonin responses in the skeletal muscle microcirculation. Life Sci. 34:1984;1135-1141.